SCHEMBL23770543

SCHEMBL23770543

Cc1cccc(C)c1-c1nc(NSc2ccnc(N)c2)ccc1C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.35
NOS3 P29474 2/20 0.33
NOS2 P35228 2/20 0.33
PTPN1 P18031 1/20 0.31
SYK P43405 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
NOS1 P29475 1/20 0.30
KMT2A Q03164 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
CYP2C19 P33261 1/20 0.30
S1PR3 Q99500 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770773 0.83 ABL1 (0.37) S1PR1NOS3NOS2
SCHEMBL23770552 0.83 JAK2 (0.33) NOS3NOS2KDM4EMEN1NOS1
SCHEMBL23770544 0.80 S1PR1 (0.33) S1PR1SYK
SCHEMBL23770405 0.80 PTPN1 (0.31) NOS3NOS2PTPN1
SCHEMBL19925400 0.77 HSD11B1 (0.41) SYKKDM4E
SCHEMBL29464326 0.77 HSD11B1 (0.41) SYKKDM4E
SCHEMBL23770613 0.77 CYP1A2 (0.37) S1PR1PTPN1MEN1KMT2ALMNA
SCHEMBL23770695 0.75 CYP1A2 (0.34) NOS3NOS2KDM4EMEN1NOS1
SCHEMBL23770732 0.74 NOS3 (0.38) S1PR1NOS3NOS2SYKLMNA
SCHEMBL23770551 0.71 PTPN1 (0.36) PTPN1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed